SCHEMBL26564751

SCHEMBL26564751

Cc1ccc(-c2ccc3cc(-c4ccc(-c5cccc6ccccc56)nc4)ccc3c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 5/20 0.44
CYP11B2 P19099 5/20 0.44
FLT3 P36888 1/20 0.43
ENPP3 O14638 1/20 0.41
ENPP1 P22413 1/20 0.41
PIM1 P11309 1/20 0.41
ALDH1A1 P00352 2/20 0.40
HPGD P15428 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2C9 P11712 2/20 0.40
TSHR P16473 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSD17B10 Q99714 1/20 0.40
PARP1 P09874 1/20 0.40
KDM4E B2RXH2 1/20 0.40
CA12 O43570 4/20 0.40
CA1 P00915 4/20 0.40
CA2 P00918 4/20 0.40
CA9 Q16790 4/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26567174 0.96 CYP11B1 (0.43) CYP11B1CYP11B2FLT3ENPP3ENPP1
SCHEMBL26564770 0.90 CYP11B1 (0.44) CYP11B1CYP11B2PIM1ALDH1A1HPGD
SCHEMBL26548183 0.87 CYP11B1 (0.40) CYP11B1CYP11B2ENPP3ENPP1PIM1
SCHEMBL26548180 0.86 L3MBTL1 (0.46) CYP11B1CYP11B2PIM1CYP1A2CYP3A4
SCHEMBL26551572 0.86 PIM1 (0.41) CYP11B1CYP11B2ENPP3ENPP1PIM1
SCHEMBL26551585 0.86 BMX (0.43) CYP11B1CYP11B2PIM1ALDH1A1CYP1A2
SCHEMBL26548182 0.83 TRPV1 (0.41) CYP11B1CYP11B2ENPP1PIM1HPGD
SCHEMBL26554492 0.83 BMX (0.42) CYP11B1CYP11B2PIM1ALDH1A1CYP1A2
SCHEMBL26554461 0.83 PIM1 (0.40) CYP11B1CYP11B2ENPP3ENPP1PIM1
SCHEMBL26548693 0.83 CASP3 (0.45) CYP11B1CYP11B2PIM1CYP1A2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AOC1, ODC1, PIEZO1 CYP11B1 1676/4885CYP11B2 1913/4885FLT3 4656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.